CS270145B1 - 6-Benzylidénaaina-2-p-hexyltiehenzetiazal - Google Patents

6-Benzylidénaaina-2-p-hexyltiehenzetiazal Download PDF

Info

Publication number
CS270145B1
CS270145B1 CS888362A CS836288A CS270145B1 CS 270145 B1 CS270145 B1 CS 270145B1 CS 888362 A CS888362 A CS 888362A CS 836288 A CS836288 A CS 836288A CS 270145 B1 CS270145 B1 CS 270145B1
Authority
CS
Czechoslovakia
Prior art keywords
compound
odlereva
ethanol
hexyltiehenzetiazal
benzylidénaaina
Prior art date
Application number
CS888362A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS836288A1 (en
Inventor
Eva Ing Csc Sidoova
Zelmira Mudr Csc Odlerova
Karel Doc Rndr Csc Waisser
Original Assignee
Sidoova Eva
Odlerova Zelmira
Karel Doc Rndr Csc Waisser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidoova Eva, Odlerova Zelmira, Karel Doc Rndr Csc Waisser filed Critical Sidoova Eva
Priority to CS888362A priority Critical patent/CS270145B1/en
Publication of CS836288A1 publication Critical patent/CS836288A1/en
Publication of CS270145B1 publication Critical patent/CS270145B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Β·1 připravený dateraz neznéay 6- -henzylidénaaina-2-n-hexyltiahenzatiaζ·1 vzarca I..Syntéza uvedenej zlúčenin . ny sa uskutečňuje reakciau 6-aaine-2-n- -hexyltiehenzetiazelu e henzaldehydea v etanele za varu. Zlúčenina je antiaykehakteriélne účinná prati typicljýa a * atypický* tuherkuleznya aykehakteriáa, najafi prati Mycehaeteriua fartuitua.Β·1 prepared hitherto unknown 6- -hexylideneamine-2-n-hexylthiahenzathiaζ·1 formula I..The synthesis of the above compound. ny is carried out by the reaction of 6-amine-2-n- -hexylthiahenzathiazel and henzaldehyde in ethanol at boiling. The compound is antibacterially effective against typical and * atypical* tuberculosis bacteria, especially against Mycehaeteriua fartuitua.

Description

Predaetoa vynálezu je 6-kenzylidénaaino-2-n-kexyltiokenzotiazol.The present invention is 6-kenzylideneamino-2-n-kexylthiokenzothiazole.

Deteraz koli znáae viaceré antiaykokakteriálne účinné deriváty kenzotiazolu. /Sidéevá, E. a Odlerevá, Ž., 6sl. Λ0 189212 /1978/, Sidéevá, E. a Odlerevá, Ž., 6el. AO 195149/1979/, Sidéevá, E. a Odlerevá, ž., Sel. AO 2Ó7299 /1980/, Sedéová, E. a Odlerevá, Ž., Čel. AO 2Í645O /1982/, Sidéevá, E. a Odlerevá, 2., 6eí. AO 225015 /1983/, Sidéevá, E. a Odlerevá, Ž., Cel. AO 239438 /1985/, Sidéevá, E, a Odlerevá, ž., Čel. AO 242017 /1985/ a $i*éová, E. a Odlerevá, 2., čel, AO 250557 /1986//. Uvedené slúčeniny aajd v poloh·'6 kenzénevéhe kruhu aainebkupinu, alek· ed nej edveáenú aaideskuyinu reap, iaideakupinuk iTo date, several anti-incocacterial active kenzothiazole derivatives are known. / Sidéevá, E. and Odlerevá, Ž., 6p. 180 189212/1978 /, Sidéeva, E. and Odlereva, Ž., 6el. AO 195149 (1979), Sidéeva, E. and Odlereva, b., Sel. AO 2Ó7299 / 1980 /, Sedéová, E. and Odlerevá, Ž., Čel. AO 2í645O / 1982 /, Sidéeva, E. and Odlereva, 2., 6eí. AO 225015 (1983), Sidéeva, E. and Odlereva, Ž., Cel. AO 239438/1985 /, Sidéeva, E, and Odlereva, b., Cel. AO 242017 (1985) and E. and Odlereva, 2., front, AO 250557 (1986). Said compounds are also in the 6-position of the kenzene ring of the aaine group, but also of the aaideskuyine reap, iaideakupinuk i

Teraz eae zistili, íe deteraz neznáaa zlúčenina xaerca I ’Now eae have found that the compound xaerca I ’is still unknown.

je antiaykokakteriálne účinná preti typickýa a atypiokýa tukerkuléznya aykokaktériáa najati pretl Myoekaoteriua /H,/ fertuitua. Súčaene hal zlatěný eyéaok propravy uvodonej zlúčeniny na káze S-aalne-2-n-hexyltiekenzetiazelu /Sidéevá, E. a Odlerevá, Ϊ., čel. AO 829212/1978//, který aa vyznačuje týa, le 6-aaine-2-j»-hoxyltioken«otiasol aa nooká roagov-ať a ekvivalentnýa anožstvea kenzaldehydu v etanOle za varu, ' , ' |is an antiaycocacterial active against typical and atypical fat-based myocardial lysis and is mediated by Myoekaoteriua / H, / fertuitua. The combined hal gold eyéaok of the preparation of the title compound on the S-aalne-2-n-hexylthienzenzetiazel sermon [Sidéevá, E. and Odlerevá, Ϊ., Č. AO 829212 (1978), which denotes 6-aaine-2-j-ethoxylthiokene otiasol aa nook roagov-a and an equivalent amount of kenzaldehyde in ethanol at boiling, ',' |

Nasledujúee příklady kližSie osvetťujú, ale nijaké neekaedzujú přípravu a vlastnosti zlúčeniny podía vynálezu.The following examples illustrate, but do not limit, the preparation and properties of the compound of the invention.

Příklad 1Example 1

Příprava 6-kenzylidénanine-2-n-kexyltiokenzotia2oluPreparation of 6-benzylideneanine-2-n-kexylthiokenzothiazole

6-Aaino-2-hexyltiokenzotiazol /5,3 g, 0,02 ael/ aa rozpustil v etanele /20 oa3/, k rezteku ea přidal kenzaldehyd /2,1 gt 0,02 ael/ a reakčná zaee aa zahriala na 5 áinút do varu. K reakčnej zaeei po eohladení áa tepletu aieatneati sa přidala studená veda /10 oaV a po 3 hodinách sa izeleval surový predukt e t.t. 73 až 74,5 *0 v anožstve 3,6ig /50,7 ¢/.6-Amino-2-hexyltiokenzotiazol / 5.3 g, 0.02 AEL / a, dissolved in etanele / 20 o 3 /, e and added to rezteku kenzaldehyd / 0.02 2.1 g t AEL / aa, and the reaction warmed to zaee 5 minutes to boil. Cold science (10 ° C) was added to the reaction mixture after cooling to room temperature, and after 3 hours, the crude product was collected in an amount of 73-74.5% in an amount of 3.6 μg (50.7%).

Látka kela prekryStalizevaná ze nesl etanel. - veda v peaere 4j_l za peužitia aktívnehe uhlia. Získal sa čistý 5-kenzylidénaaihe-2-n-hsxyltiokenzotiazol s t.t.73,5 až 74,5 *0, M.h. i 354,54. ।'Kela fabric overlaid from supported ethanol. - science in peaere 4j_l for the use of activated carbon. Pure 5-benzylidene and 2-n-hexylthiokenzothiazole were obtained, m.p. 73.5-74.5%, M.h. and 354.54. । '

Pře ^20^22^2^2 vypočítané fit C 67,76 H 6,25 N 7,90 S 18,09 zistené 67,85 6,53 7,8518,22For ^ 20 ^ 22 ^ 2 ^ 2 calculated fit C 67.76 H 6.25 N 7.90 S 18.09 found 67.85 6.53 7.8518.22

Příklad 2 'Example 2 '

Antiaykekakteriálna účinnost* zlúčeniny. pedía vynálezu v porovnaní a účinnesťeu Izeniketínhydrazidu a 2-aerkaptekenzotiazolu.Antiaykecacterial activity * of the compound. according to the invention in comparison with the efficacy of iseniketin hydrazide and 2-aeraptecenzothiazole.

Antiaykekakteriálna účinnesť preti tukerkuléznya nykekaktdriáa k«la slddevaná v tekuté j Sulevej pSde zrieievaoía testea. Ake rezpúžťadle kel peužitý iiaetylsulfexid. VýslednáThe antifungal activity has been shown to be effective in liquid treatment in a liquid solution. The solvent used is ethyl sulfexide. The resulting

kenoentráoia látek v plde kela 0,5, 1, 1,5^ 10, 25, 50 a lOO^ig oa · , kenoentration of substances in the field of 0.5, 1, 1.5 ^ 10, 25, 50 and 100 ^ oig oa ·, Látka. . . Fabric. . . • MIC oproti Myookaoteriun • MIC vs. Myookaoteriun tko. H37®vtko. H 37®v kansasli PKO 8 kansasli PKO 8 aviua 80/72 0 aviua 80/72 0 fertuitua fertuitua Zlúčenina pedla příkladu 1. The pedal compound of Example 1. 10 /50/ 10/50 / ' 25 /10/ '25/10 / 50 50 25 25 INH INH 1 1 10 10 100 100 100 100 2-MBT 2-MBT 10 10 25 25 100 100 50 50

MIC « ainiaálna inhikičná kenoentráoia vMg oa“\ INH Izeniketínhydrazid, 2-MBT . 2-aerkaptekenzetiaZel. Siastečná inhikičná kenoentráoia je udaná v zátverke.MIC: Initial Inhibitory Kenoenterology in Mg O 2 Isinethetine Hydrazide, 2-MBT. 2-aerkaptekenzetiaZel. The partial injection kenoentration is given in parentheses.

CS 270 145 BlCS 270 145 Bl

Významný je fakt, že zlúčenina pedía vynálezu avejeu účinnesteu preti M. avium převyšuje zavedený preparát Izeniazid /INH, Izeniketínhydrazid/ dvejnásebne a účinneeťeu preti M. fertuitum štvernásebne, pritem má účinnesť perevnatáínú a účinnesteu uvedenéhe preparátu preti M. tu>erculesÍB Ηβ7®ν a M· kanaasii.Important is the fact that the compound of the invention specialization avejeu účinnesteu preti M. avium exceeds the established formulation Izeniazid / INH Izeniketínhydrazid / dvejnásebne and A. Preti účinneeťeu fertuitum štvernásebne, pritem the účinnesť perevnatáínú and účinnesteu uvedenéhe preparation A. Preti here> erculesÍB Ηβ7® and ν M · kanaasii.

Zlúčeninu pedťa vynálezu nežne peužívat ake účinnú zležku antimykebakteriálnych prípravkev, alete ake medzlpredukt pre dalšie syntézy.The compound of the present invention cannot be used as an effective ingredient of antimycebacterial agents, but also as an intermediate for further syntheses.

Claims (2)

PREDMET VYNÁLEZUOBJECT OF THE INVENTION 1. 6-Benzyli4énamine-2-n-hexyltie>enzetiazel vzerca I1. 6-Benzyl-4-amenine-2-n-hexyl-thiazethiazel of formula I 2. Speseli přípravy zlúčeniny pedía bědu 1 vyznačený tým, že sa nechá reagsvať 6-a*in«-2-n-hexyltietenzetiazel e ekvivalentným anežstvem benzaldehydu v etanele za varu pe detu 1 až 30 minút.2. Special preparations for the preparation of the compound of step 1, characterized in that 6-α-indole-2-n-hexylthiethenzethiazole is reacted with an equivalent amount of benzaldehyde in ethanol for 1 to 30 minutes.
CS888362A 1988-12-16 1988-12-16 6-Benzylidénaaina-2-p-hexyltiehenzetiazal CS270145B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS888362A CS270145B1 (en) 1988-12-16 1988-12-16 6-Benzylidénaaina-2-p-hexyltiehenzetiazal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS888362A CS270145B1 (en) 1988-12-16 1988-12-16 6-Benzylidénaaina-2-p-hexyltiehenzetiazal

Publications (2)

Publication Number Publication Date
CS836288A1 CS836288A1 (en) 1989-09-12
CS270145B1 true CS270145B1 (en) 1990-06-13

Family

ID=5434060

Family Applications (1)

Application Number Title Priority Date Filing Date
CS888362A CS270145B1 (en) 1988-12-16 1988-12-16 6-Benzylidénaaina-2-p-hexyltiehenzetiazal

Country Status (1)

Country Link
CS (1) CS270145B1 (en)

Also Published As

Publication number Publication date
CS836288A1 (en) 1989-09-12

Similar Documents

Publication Publication Date Title
TWI337998B (en) Substituted imidazoles
DE69132961T2 (en) STYRYL-SUBSTITUTED HETEROARYL COMPOUNDS INHIBITING EGF RECEPTOR TYROSINE KINASE
BE851310A (en) NEW DERIVATIVES OF TETRAHYDRO-EQUINOCANDIN B
HUE025466T2 (en) Nitrocatechol derivatives as comt inhibitors
ZA200601586B (en) Caspase inhibitors containing isoxazoline ring
JP3186771B2 (en) A new selective aromatase inhibitor
WO1997032873A1 (en) Quinoxalinediones
CA1265794A (en) 4h-triazolo[4,3-a][1,4] benzodiazepin compounds, process for preparation thereof, their applications as drugs and compositions containing same
JPS60100560A (en) Antidepressive 1,2,4-triazolone compound
HU203076B (en) Process for producing arylhydroxamic acid derivatives and pharmaceutical compositions comprising such compounds, as well as composition regulating plant growth and delaying fading of cut flowers
US4602093A (en) Novel substituted imidazoles, their preparation and use
FR2464264A1 (en) 6- (PYRIDINYL) -3 (2H) PYRIDAZINONES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
JPS6261960A (en) Non reversible dopamine-beta-hydroxylase inhibitor
CS270145B1 (en) 6-Benzylidénaaina-2-p-hexyltiehenzetiazal
FR2612517A1 (en) BENZOXAZINE DERIVATIVES, METHODS FOR PREPARING THESE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
NO143316B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW OXSAZOLIDINONS WITH PHARMACODYNAMIC PROPERTIES
FR2499991A1 (en) NOVEL 2,1,3-BENZOTHIADIAZOLES AND 2,1,3-BENZOXADIAZOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES
CH633541A5 (en) Pharmacologically active substituted 1,2,4-triazines and medicaments containing these triazines
TWI387457B (en) Quinoline derivatives as antibacterial agents
US4288448A (en) N-Substituted imidazole derivatives, and their use
TWI392494B (en) Quinoline derivative as an antibacterial agent (1)
CH630909A5 (en) New 3,5-disubstituted-1H-1,2,4-triazoles
JP3439249B2 (en) New pyrrole-type compound and hair growth / hair growth promoter
AP982A (en) Quinoxalinediones.
CA1329601C (en) Cardiotonic tricyclic oxazolones